Influenza viruses, which belong to the family of Orthomyxoviridae, are classified into three types: A, B, and C (31) . The genomes of A-and B-type influenza viruses consist of eight single-stranded, negative-sense RNA segments, whereas influenza C viruses have only seven RNAs (31) . Both A and B influenza viruses contain two major surface glycoproteins: the hemagglutinin (HA), possessing the receptor-binding and fusion activities; and the neuraminidase (NA), which destroys the receptor by cleaving sialic acid from host cell membranes, thereby releasing newly formed virus particles (31) . Influenza C viruses contain only one major surface glycoprotein, HEF (hemagglutinin-esterase fusion), which has the receptor-binding fusion as well as receptor-destroying/esterase activities (13, 31) . HEF forms a homotrimer and binds to 9-O-acetylneuraminic acid on the cell surface, while the HAs of influenza A and B viruses, which also form a homotrimer, instead recognize N-acetylneuraminic acid as their receptors (31) . The fusion activity of both HEF and HA requires proteolytic cleavage of the full-length precursor into two disulfide bond-linked subunits: HEF 0 into HEF 1 and HEF 2 and HA 0 into HA 1 and HA 2 . After cleavage, the fusion peptide on the HEF 2 or HA 2 subunit is able to mediate membrane fusion upon the low pH activation in the endosome (12, 31) .
A late step of influenza virus replication in cells involves the packaging of each individual viral RNA (vRNA) segment into budding virions, in an equimolar manner. The mechanism of vRNA packaging is not fully understood. Two models have been proposed for influenza A virus: the random incorporation model and the selective packaging model (31) . The random incorporation model argues that all vRNA segments possess a common packaging feature and are incorporated indiscriminately, with the result that full genomes are assembled only by chance (1, 6) . The selective packaging model argues that each RNA segment has a specific feature-the unique packaging sequence-which allows the selective incorporation of eight segments into a budding virion. Recently, evidence supporting the specific packaging model has accumulated. Several groups have found that the 5Ј and 3Ј noncoding sequences as well as sequences at both ends of the coding region are important for vRNA packaging (9, 10, 18, 19, 21, 22, 25, 29, 30, 43) . Utilizing these packaging sequences, foreign transgenes can be carried by the influenza virus either transiently, only for several passages, or stably, for multiple passages (20, 21, 36, 43) .
Reverse genetics, the generation of negative-sense RNA virus from cloned cDNA, has revolutionized research on influenza virus (8, 27) . Methods to rescue all three types of influenza viruses, A, B, and C, have been successfully established (5, 8, 14, 15, 24, 27) . Reverse genetics has been utilized to study the influenza viral replication cycle, to characterize the function of influenza viral proteins, and to understand the high pathogenicity of the 1918 and H5N1 viruses (4, 11, 16, 39, 44) . Reverse genetics can also be used to design live attenuated vaccines, such as influenza A and B viruses expressing altered type I interferon antagonist (NS1) proteins, live in ovo vaccine against avian influenza and Newcastle disease viruses, and H5N1 influenza A virus carrying an M2 protein with deletions in the cytoplasmic tail (37, 38, 42) . Because the replication cycle of influenza virus lacks a DNA phase, the viral genome cannot integrate into the host genome. This property makes the influenza virus a promising, safe candidate for a vaccine or gene delivery vector (28) . With reverse genetics, foreign RNAs that are flanked by influenza virus packaging sequences can be incorporated into influenza virions, allowing the expression of foreign proteins in infected host cells (21, 36, 43) .
In this study, we substituted the two major glycoproteins of influenza virus A/Puerto Rico/8/34 (A/PR/8/34) virus, HA and NA, with the single major glycoprotein of influenza virus C/Johannesburg/1/66 (C/JHB/1/66) virus, HEF, and successfully generated two seven-segmented chimeric influenza viruses. The two viruses each possess six influenza A virus RNA segments (PB1, PB2, PA, NP, M, and NS) and one chimeric RNA segment encoding either the influenza C virus HEF full-length protein or the chimeric protein HEF-Ecto, which consists of HEF ectodomain and HA transmembrane and cytoplasmic regions. Both HEF and HEF-Ecto RNA segments carry sequences from A/WSN/33 HA RNA at the two ends to allow packaging into virions. Furthermore, both viruses are able to stably incorporate one extra green fluorescent protein (GFP) RNA segment carrying the NA packaging sequences, demonstrating a new approach to developing a vaccine or gene delivery vector.
nucleotides of packaging sequences from the NA ORF. The GFP ORF was derived from the previously constructed pPOL I HA(45)GFP(80) plasmid (21) . The plasmid pDZ-GFP-2, with 153 and 181 nucleotides of NA ORF packaging sequences at the 3Ј and 5Ј ends of GFP, was constructed by using similar methods. The three ATG codons before the NheI site were also mutated to TTG by site-directed mutagenesis. Sequences of primers used for cloning and sitedirected mutagenesis are available from the authors upon request.
Reverse genetics for recombinant viruses. The method for generating recombinant influenza viruses was modified from previously described protocols (8, 33) . Briefly, for the generation of HEF-or HEF-Ecto-containing viruses, 293T cells were transfected with six A/PR/8/34 plasmids (pDZ-PB2, pDZ-PB1, pDZ-PA, pDZ-NP, pDZ-M, and pDZ-NS), one pPOL I-HEF or pPOL I-HEF-Ecto plasmid, three A/WSN/33 protein expression plasmids (pCAGGS-HA, pCAGGS-NA, and pCAGGS-NS1), plus or minus the GFP plasmid (pDZ-GFP-1 or pDZ-GFP-2). For the generation of recombinant A/PR/8/34 (rA/PR/ 8/34) virus expressing the A/WSN/33 HA and NA, six A/PR/8/34 plasmids (pDZ-PB2, pDZ-PB1, pDZ-PA, pDZ-NP, pDZ-M, and pDZ-NS) and two A/WSN/33 plasmids (pPOL I-HA and pPOL I-NA) were used to transfect 293T cells. The plasmids (0.5 g each) were added in one well of a six-well plate. Twenty-four hours posttransfection, the supernatants and cells were harvested and inoculated into 8-or 10-day-old embryonated chicken eggs, and the eggs were incubated at 33°C for three days. The allantoic fluids were harvested and subjected to hemagglutination assay to determine the presence of viruses.
Western blotting. Viruses were grown in 8-or 10-day-old chicken embryos at 33°C or 37°C for two to three days. The allantoic fluids were harvested, and the viruses were purified by centrifugation through a 30% sucrose cushion. Purified viruses were resuspended in 1ϫ phosphate-buffered saline (PBS) and lysed in 2ϫ protein loading buffer (100 mM Tris-HCl [pH 6.8], 4% sodium dodecyl sulfate, 20% glycerol, 5% ␤-mercaptoethanol, and 0.2% bromophenol blue). The protein lysates were separated on a 10% sodium dodecyl sulfate-polyacrylamide gel and transferred to a nitrocellulose membrane (Whatman, Inc.). The membrane was then probed with mouse monoclonal antibody against A/PR/8/34 NP protein (HT103, 1 g/ml), A/WSN/33 HA protein (2G9, 1 g/ml), or C/JHB/1/66 HEF protein (8D6D3, 1 g/ml).
Acrylamide gel electrophoresis of purified vRNA. The viruses were grown in 8-to 10-day-old embryonated chicken eggs at either 33°C for HEF-or HEF-Ectocontaining viruses or 37°C for rA/PR/8/34 virus expressing the WSN HA and NA. Two to three days later, the embryos were killed by transferring them to 4°C and were left overnight. The allantoic fluids were harvested and clarified by centrifugation at 6,000 rpm at 4°C for 15 min using a Beckman rotor SW28. Clarified supernatant was then layered on a 30% sucrose cushion and further centrifuged at 25,000 rpm for 2.5 h. Pelleted virus was resuspended in 1ϫ PBS buffer, and vRNA was extracted by using TRIzol reagent (Invitrogen). Precipitated vRNA was resuspended in a final volume of 15 l DNase-and RNase-free H 2 O and stored at Ϫ80°C. RNA (0.5 to 1 g) was separated on a 2.8% denaturing polyacrylamide gel containing 7 M urea. The gel was stained with a SilverXpress silver staining kit (Invitrogen) to visualize the RNA bands.
Immunostaining of plaques. The protocol was modified from a previously reported method (23) . Briefly, a MDCK cell monolayer in six-well plates was infected with viruses in serial 10-fold dilutions for 1 h and covered with agar overlay containing 1 g/ml L-1-tosylamide-2-phenyl-ethyl chloromethyl ketone (TPCK)-trypsin (Sigma). Two to three days later, the cells were fixed with 4% formaldehyde containing 0.01% Triton X-100 for 3 h. The agar overlay was removed and blocked with 1ϫ PBS containing 5% dried nonfat milk and 0.05% Tween 20 for 1 h at room temperature. Then, the cells were incubated overnight with the first antibody: rabbit anti-A/PR/8/34 polyclonal antibody for rA/PR/8/34 virus expressing the A/WSN/33 HA and NA (1:2,000 dilution); or mouse anti-HEF monoclonal antibody (8D6D3, 1 g/ml) for HEF-and HEF-Ecto-containing viruses and influenza C/JHB/1/66 virus. The cell monolayer was washed with PBS and incubated for 1 h at room temperature with Amersham ECL-HRP linked anti-rabbit or anti-mouse secondary antibody (GE Healthcare). The cells were washed three times with PBS and stained with TrueBlue peroxidase substrate (KPL).
Viral growth kinetics. Eight-day-old embryonated chicken eggs were inoculated with influenza viruses (100 PFU/egg) and incubated at 33°C. At 24, 48, and 72 h postinoculation, the eggs were transferred to 4°C and left overnight, after which the allantoic fluids were harvested. The titer of the viruses was determined by plaque assay or immunostaining of the plaques in MDCK cells.
RESULTS

Generation of recombinant seven-segmented influenza viruses.
In this study, we attempted to generate an influenza A (B) Genome structure of seven-segmented HEF or HEF-Ecto virus. Six A/PR/8/34 ambisense plasmids (pDZ-PB2, pDZ-PB1, pDZ-PA, pDZ-NP, pDZ-M, and pDZ-NS) and one pPOL I plasmid (pPOL I-HEF or pPOL I-HEF-Ecto) were used to generate the recombinant HEF or HEF-Ecto virus by using reverse genetics (8, 33) . (C) Incorporation of HEF full-length or HEF-Ecto chimeric glycoprotein into the recombinant seven-segmented virions. The rA/PR/8/34 virus expressing the A/WSN/33 HA and NA (rA/PR/8/34ϩWSN HA, NA), which was grown at 37°C, and three viruses (C/JHB/1/66, HEF, and HEF-Ecto) which were grown at 33°C were inoculated into 8-or 10-day-old embryonated chicken eggs. Two to three days later, allantoic fluids were harvested and virions were purified by centrifugation through a 30% sucrose cushion. A Western blot was performed to detect the presence of HEF, NP, and HA proteins using specific monoclonal antibodies. (D) The genome of HEF or HEF-Ecto virus contains seven RNA segments. RNA was isolated from purified rA/PR/8/34 expressing the A/WSN/33 HA and NA, HEF, and HEF-Ecto viruses, run on a 2.8% acrylamide gel, and visualized by silver staining. RNA (0.5 to 1 g) was loaded for each virus. Each RNA segment is labeled to the right of the gel. (E) Immunostaining of viruses grown in MDCK cells. Confluent MDCK cells were infected with rA/PR/8/34 expressing the A/WSN/33 HA and NA and the C/JHB/1/66, HEF, and HEF-Ecto viruses at a multiplicity of infection of 0.0001, covered with agar overlay containing 1 g/ml TPCK-trypsin, and incubated at either 37°C or 33°C. Two to three days postinfection, the agar overlay was removed after formaldehyde fixation. The cells were incubated at 4°C overnight with rabbit polyclonal antiserum against A/PR/8/34 for the rA/PR/8/34 virus expressing the A/WSN/33 HA and NA or with mouse monoclonal antibody against HEF for the C/JHB/1/66, HEF, and HEF-Ecto viruses. The second day, the cells were incubated with horseradish peroxidase-linked anti-rabbit or anti-mouse immunoglobulin G for 1 h at room temperature, and the "plaques" were visualized by using TrueBlue peroxidase substrate. (Fig. 1B) , except that one additional construct, pDZ-GFP-1 or pDZ-GFP-2, was also included in the rescue transfection. (C) Incorporation of HEF full-length or HEF-Ecto chimeric glycoprotein into the recombinant HEFϩGFP or HEF-EctoϩGFP virions. The experiment was performed together with that shown in Fig. 1C. (D, E) GFP-1 or GFP-2 RNA is incorporated into HEFϩGFP (D) and HEF-EctoϩGFP (E) virions. The method was the same as that described in the legend for Fig. 1D. (F, G) Expression of GFP in 293T cells by the recombinant HEFϩGFP (F) and HEF-EctoϩGFP (G) viruses. 293T cells were infected with recombinant HEF, HEFϩGFP-1, or HEFϩGFP-2 (F) viruses or with HEF-Ecto, HEF-EctoϩGFP-1, or HEF-EctoϩGFP-2 (G) viruses at a multiplicity of infection of 0.5. The expression of GFP was observed 8 h postinfection. (Fig. 1A) . The original HA translation start codon ATG was mutated to CTG, such that the HEF protein is translated from its own initiation codon (Fig. 1A) .
Although the overall structures are similar, HA and HEF only share about 12% sequence identity (35) . Compared to HA, C/JHB/1/66 HEF has a shorter transmembrane domain and cytoplasmic tail, which are 20 and 3 amino acids long, respectively (26, 32) . In addition, for HEF, the cysteine residue next to the cytoplasmic domain is acylated with stearic acid, while for HA, the cysteine residues of C-termini undergo palmitoylation (40, 41) . Considering these differences and the possibility that the C-terminal portion of the HA protein may be required for the assembly of virions (3, 45, 46), we also generated an HEF-Ecto chimeric gene, in which the 1,893-bp ORF encoding the HEF ectodomain was fused to the sequences encoding the HA transmembrane and cytoplasmic domains (Fig. 1A) . The HEF-Ecto chimeric gene is also flanked by HA NCRs and 45 nucleotides of packaging sequence from the HA ORF that are proximal to the start codon. Expression of both HEF and HEF-Ecto RNAs is driven by a human RNA polymerase I promoter and terminated with the hepatitis delta virus ribozyme sequence.
By using previously established methods (see Materials and Methods), two chimeric HEF-and HEF-Ecto-containing viruses (hereafter called the HEF and HEF-Ecto viruses) were successfully rescued (Fig. 1B) and were found to be stable for at least five passages in embryonated chicken eggs. HEF virus contains six RNA segments (PB2, PB1, PA, NP, M, and NS) from A/PR/8/34 and one HEF segment flanked by the influenza A virus packaging sequences. HEF-Ecto virus contains the same six backbone segments from A/PR/8/34 and one HEF-Ecto chimeric segment (Fig. 1B) . In order to characterize the protein compositions, the viruses were grown in the allantoic cavities of embryonated chicken eggs and purified by centrifugation through a 30% sucrose cushion. Western blotting was performed to detect the presence of individual proteins using specific monoclonal antibodies. The results showed that both HEF and HEF-Ecto viral particles contain the A/PR/8/34 NP and the C/JHB/1/66 glycoprotein HEF 1 , which is the proteolytic cleavage product of full-length precursor HEF 0 . Both viruses were also shown not to contain influenza A virus HA (Fig. 1C) , since HA 1 , the cleavage product of full-length HA 0 , is only detected in rA/PR/8/34 virus expressing the A/WSN/33 HA and NA. In order to show that the newly obtained HEF or HEF-Ecto chimeric virus indeed contains seven RNA segments, RNA was purified and run on an acrylamide gel to visualize the genome compositions by silver staining (Fig. 1D) . The results showed that both HEF and HEF-Ecto viruses contain seven RNA segments: PB2, PB1, PA, NP, M, NS, and one chimeric segment, HEF or HEF-Ecto. The chicken 18S rRNA derived from ribosomes, which were copurified with virions, was also visible on the gel. Both viruses lack the influenza A virus RNA segments HA and NA, which are present in rA/PR/8/34 virus expressing the A/WSN/33 HA and NA (Fig.  1D) . It should be noted that the abundance of A/WSN/33 NA vRNA in the A/PR/8/34 background is low possibly because of inefficient packaging (Fig. 1D) . Interestingly, the intensity of the HEF segment RNA from the HEF virus is about 50% less than that of the corresponding PA segment, while the HEFEcto RNA segment of the HEF-Ecto virus is comparable to that of PA (Fig. 1D) . This indicates that the packaging efficiency of the HEF-Ecto RNA segment is higher than that of HEF RNA, which may be due to the presence of longer HA packaging sequences at the 5Ј end (Fig. 1A) .
When traditional plaque assay methods are used, the influenza C/JHB/1/66 virus does not lyse cells and forms clear plaques in MDCK cells (34) . In this study, we found that the newly rescued HEF and HEF-Ecto chimeric viruses grew very poorly in MDCK cells and were also unable to form visible plaques by regular plaque assay methods. Thus, in order to titrate the C/JHB/1/66, HEF, and HEF-Ecto viruses, we performed immunostaining of plaque assays, using a method modified from a previous report (23) . Briefly, the viruses were subjected to regular plaque assay using MDCK cells. After fixation with formaldehyde, instead of staining the cell monolayer with crystal violet, we used specific monoclonal antibody against HEF protein and peroxidase substrate to visualize the "plaques" (Fig. 1E) . At 33°C, C/JHB/1/66 forms bigger "plaques" than both the HEF and HEF-Ecto viruses, and the "plaques" formed by HEF-Ecto are the smallest (Fig. 1E) .
Generation of HEF or HEF-Ecto viruses carrying a GFP RNA segment. The selective packaging model argues that eight segments are required for efficient packaging of influenza A virus genomes (9, 10, 18, 19, 21, 22, 25, 29, 30, 43) . If this model is correct, the HEF or HEF-Ecto chimeric viruses could be modified to carry one additional RNA segment that contains the NA packaging sequences. To determine whether this is the case, we generated GFP constructs in which the GFP ORF is flanked by the A/PR/8/34 NA 3Ј and 5Ј packaging sequences: pDZ-GFP-1 and pDZ-GFP-2 ( Fig. 2A) . GFP-1 carries 111 and 157 nucleotides of the NA coding region flanking the 3Ј and 5Ј ends, respectively, and GFP-2 carries slightly longer sequences from the NA ORF, 153 and 181 nucleotides at the 3Ј and 5Ј ends, respectively. Because the packaging sequences of the A/PR/8/34 NA segment have not been characterized, we tested shorter NA terminal sequences in pDZ-GFP-1 and longer sequences in pDZ-GFP-2. All ATG codons before the GFP translation initiation codon in both constructs were mutated to TTG; thus, the translation of GFP utilized its own start codon. Unpublished data from our lab showed that mutating these ATGs did not interfere with vRNA packaging. GFP-1 and GFP-2 chimeric genes are expressed from the ambisense pDZ plasmids, which were described previously (33) . By using reverse genetics techniques, we successfully rescued the GFPcarrying HEF and HEF-Ecto viruses (HEFϩGFP and HEFEctoϩGFP), each of which contains the six A/PR/8/34 backbone segments (PB2, PB1, PA, NP, M, and NS), one chimeric segment HEF or HEF-Ecto, and one extra segment GFP-1 or GFP-2 (Fig. 2B) . Western blot results showed that both HEFϩGFP and HEF-EctoϩGFP virions contain A/PR/ 8/34 NP and C/JHB/1/66 glycoprotein HEF 1 but not HA (Fig.  2C) . Furthermore, to show that both viruses do contain the GFP segment, the RNA was isolated from purified viruses and run on an acrylamide gel to visualize the viral genome compositions by silver staining (Fig. 2D and E) . GFP-1 and GFP-2 RNA segments can be seen in both HEFϩGFP (Fig. 2D) and HEF-EctoϩGFP (Fig. 2E ) virions, and with similar incorporation efficiencies. Consistent with this result, GFP protein was expressed in 293T cells infected with viruses HEFϩGFP or HEF-EctoϩGFP, with either GFP-1 or GFP-2, but not in cells 2F and G) . Incorporation of an extra GFP segment increases the growth rate of the seven-segmented viruses. We compared the growth kinetics of HEF and HEF-Ecto viruses with or without a GFP segment, as well as those of the rA/PR/8/34 virus expressing the A/WSN/33 HA and NA and the C/JHB/1/66 virus, in 8-day-old embryonated chicken eggs at 33°C (Fig. 3) . For each virus at every time point, the allantoic fluids from three eggs were analyzed. The results showed that incorporation of a GFP-1 or GFP-2 RNA segment significantly increased the growth rate of HEF and HEF-Ecto viruses (Fig. 3B and C) . At 24 h postinoculation, the titers of both HEFϩGFP (HEFϩ GFP-1 and HEFϩGFP-2) and HEF-EctoϩGFP (HEF-Ectoϩ GFP-1 and HEF-EctoϩGFP-2) viruses were about 10 times higher than those of the seven-segmented viruses (Fig. 3B and  C) . At 48 and 72 h postinoculation, there were no significant differences in the titers (Fig. 3B and C) . These results indicate that the presence of eight RNA segments enhances viral replication, possibly through more-efficient vRNA packaging. Although HEF-Ecto virus forms much smaller "plaques" than HEF virus in MDCK cells (Fig. 1E) , no significant differences were observed for the growth rates of HEF and HEF-Ecto viruses in embryonated chicken eggs (Fig. 3B and C) . The mechanism underlying this phenomenon remains to be determined.
Stability of HEF or HEF-Ecto viruses carrying a GFP segment. The rescued HEFϩGFP-1, HEFϩGFP-2, HEFEctoϩGFP-1, and HEF-EctoϩGFP-2 viruses were passaged in 8-day-old embryonated chicken eggs to determine whether their genomes are stable over multiple passages. As shown in Fig. 4A , similar levels of GFP-2 RNA were observed for HEFϩGFP-2 virus at passage 1 and passage 7. Although the GFP-1 vRNA of HEFϩGFP-1 virus is not separable from M vRNA in the gel (Fig. 4A) , we were still able to assess its similar levels of presence at passage 1 and passage 7 by observing the GFP expression in infected cells (data not shown). The same phenomenon was also observed for HEFEctoϩGFP-1 and HEF-EctoϩGFP-2 viruses (Fig. 4B) . At passage 1 and passage 7, overall titers of the viruses were similar, and comparable levels of expression of GFP in 293T or MDCK cells were also observed. In addition, no mutations were observed for either HEF or HEF-Ecto vRNA segments after seven passages.
DISCUSSION
RNA viruses with segmented genomes can undergo reassortment when two viruses coinfect the same cell, allowing them to exchange genetic information and generate new strains which may be more adapted to the environment (31) . Although influenza A, B, and C viruses have a common ancestor, reassortment between different types has never been observed (31) . This could be due to the incompatibility of either viral proteins or vRNAs. Previously, Flandorfer et al. generated influenza A viruses carrying the full length of either the NA or HA ectodomain from influenza B virus, demonstrating a certain degree of compatibility between influenza A and B virus RNAs and proteins (7) . During the past several years, the packaging signals have been identified in each RNA segment of influenza A virus. These packaging signals not only include 3Ј and 5Ј NCRs but also the termini of each ORF, which vary in length for each segment (9, 10, 18, 19, 21, 22, 25, 29, 43) . By using the packaging sequences, foreign RNA segments can be incorporated into virions of influenza A virus (21, 36) . In this study, using the HA packaging sequences, we generated two influenza A viruses that express the influenza C virus glycoprotein HEF instead of HA and NA. Indeed, both viruses contain seven RNA segments (Fig. 1D) .
The successful rescue and the high titers of these viruses show that the influenza C virus HEF glycoprotein is fully compatible with the other influenza A viral components. This is surprising given the low (12%) amino acid sequence identity shared between HEF and HA (32, 35) . In addition, the transmembrane and cytoplasmic regions of HEF are shorter than those of HA, and the cysteine residues undergo different modifications (26, 32, 40, 41) . Despite these differences, HEF can fully replace the two glycoproteins, HA and NA, in the sevensegmented viruses generated in this study, indicating that the relatively long cytoplasmic region and palmitoylation of HA are not specifically required for influenza A virus. This conclusion is further supported by the data derived from HEF-Ecto chimeric viruses, in which the HEF ectodomain is fused to the HA transmembrane and cytoplasmic regions. Although the HEF-Ecto RNA segment has a higher packaging efficiency than that of the HEF RNA segment (Fig. 1D) , the growth rate of HEF-Ecto viruses is similar to that of HEF viruses (Fig. 3B  and C) . It is also possible that the HEF ectodomain and HA transmembrane and cytoplasmic regions used in this study may not be fully compatible with each other. Exactly how many amino acids each domain contains and especially what the optimal junction site is still need to be demonstrated.
Influenza virus is a promising candidate for vaccine vector development because its replication does not have a DNA phase and it is highly immunogenic. Previous work by Luytjes et al. first described that a chloramphenicol acetyltransferase gene segment can be maintained for several passages by influenza virus (20) . Other strategies, including inserting foreign peptides into the HA antigenic sites or the NA stalk region, have also been shown to be successful (2, 17) . In the past several years, the sequences that are required for packaging of vRNA into virions have been identified by several groups. The characterization of these packaging sequences supports a specific packaging theory, which argues that for efficient vRNA packaging of influenza A virus, eight RNA segments are required (9, 10, 18, 19, 21, 22, 25, 29, 30, 43) . How these packaging sequences function during the virion assembly process is still unclear. Foreign genes that are flanked by these sequences can be packaged into virions, which can then serve as vaccine or gene delivery vectors. In this study, the generation of HEF or HEF-Ecto viruses carrying an extra GFP segment further supports the potential of influenza viruses to act as gene vectors (Fig. 2) . Despite the fact that the HEF or HEF-Ecto viruses carrying seven RNA segments can be rescued and are stable over multiple passages, the addition of an extra segment flanked by the NA packaging sequences enhances the viral growth in embryonated chicken eggs (Fig. 3) . The fact that eight-segmented virus has a higher growth rate than the sevensegmented virus indicates that the HEF or HEF-Ecto virus is a suitable candidate to develop a vaccine or gene delivery vector. Previous work by Watanabe et al. also showed that influenza virus can carry an extra GFP-encoding segment after substituting the HA and NA segments with a segment expressing the glycoprotein of vesicular stomatitis virus (43) . The use of influenza C virus HEF protein in this study provides another example of how influenza virus can be exploited as a vaccine vector.
In conclusion, in this study we generated two seven-segmented influenza A viruses expressing the C glycoprotein HEF instead of HA and NA. Both of the viruses are able to stably carry an additional RNA segment expressing a foreign gene, indicating that the seven-segmented viruses can be used as vaccine or gene delivery vectors carrying transgenes. This study also supports the specific packaging theory of influenza vRNA incorporation into virions. 
